Markets:

Overview

News

Currencies

International

Treasuries

BioNTech SE - American Depositary Shares (NQ:BNTX)

91.39 +7.50 (+8.94%)

Streaming Delayed Price Updated: 11:18 AM EDT, Mar 11, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about BioNTech SE - American Depositary Shares

< Previous 1 2

...

25 26 27 28 29 30 31 32 33

...

72 73 Next >

BioNTech Takes A Hit Despite Doubling Profit Views, Raising 2022 Outlook ↗

November 07, 2022

BioNTech doubled profit expectations in the third quarter and raised its outlook.

Via Investor's Business Daily

Meta Goes Twitter Way With Layoffs, Twitter Might Want Some People Back After Firing Them, Coal Miners Terminate $6B Combination Discussions: Top Stories Monday, Nov. 07 ↗

November 07, 2022

Wall Street Journal

Via Benzinga

BioNTech Posts About 50% Drop In Q3 Sales and Profits Amid Falling Demand For COVID-19 Shots ↗

November 07, 2022

Via Benzinga

Risk Appetites Survive China Keeping Zero COVID Policy ↗

November 07, 2022

Chinese officials denied plans to end the zero-COVID policy and after a brief wobble, risk assets have traded better. Asia Pacific equities rallied, led by Hong Kong and mainland stocks that trade in...

Via Talk Markets

Recap: BioNTech Q3 Earnings ↗

November 07, 2022

BioNTech (NASDAQ:BNTX) reported its Q3 earnings results on Monday, November 7, 2022 at 06:00 AM. Here's what investors need to know about the announcement. Earnings BioNTech beat estimated earnings by...

Via Benzinga

BioNTech Announces Third Quarter 2022 Financial Results and Corporate Update

November 07, 2022

From BioNTech SE

Via GlobeNewswire

Week in Review: CBC Plans $137 Million Shanghai Biopharma Complex ↗

November 05, 2022

Deals, financings, trials and approvals in Chinese biotech/biopharma this week.

Via Talk Markets

Did Vaccine Stocks Just Get Their Last Boost? ↗

November 04, 2022

Some positive news sent their share prices higher, but biotech companies will need to find other ways to make money.

Via The Motley Fool

This Key Piece Of News Could Sparked BioNTech, Moderna — And Could Stoke Demand For Covid Boosters ↗

November 04, 2022

Pfizer and BioNTech tested their updated Covid booster against the original shot.

Via Investor's Business Daily

BioNTech's COVID-19 Vaccine Becomes First Foreign Shot To Be Available In Chinese Market ↗

November 04, 2022

German Chancellor Olaf Scholz agreed to allow expatriates in China to use BioNTech SE (NASDAQ: BNTX) made COVID-19 vaccine. BioNTech would be the first non-Chinese coronavirus vaccine in China, as...

Via Benzinga

Pfizer/BioNTech Updated Omicron Adapted COVID-19 Vaccine Shows 4-Fold Higher Neutralizing Activity ↗

November 04, 2022

Via Benzinga

Pfizer and BioNTech Announce Updated Clinical Data for Omicron BA.4/BA.5-Adapted Bivalent Booster Demonstrating Substantially Higher Immune Response in Adults Compared to the Original COVID-19 Vaccine

November 04, 2022

From BioNTech SE

Via GlobeNewswire

November 04, 2022

From Pfizer Inc.

Via Business Wire

BioNTech Shares Up On Hope For Combined Flu, Covid Shot ↗

November 03, 2022

The shot will combine Pfizer's quadrivalent flu shot with the bivalent Covid booster.

Via Investor's Business Daily

Pfizer, BioNTech Launch Omicron-Adapted COVID Shot-Flu Combination Vaccine Study ↗

November 03, 2022

Via Benzinga

Why Inovio Pharmaceuticals Stock Zoomed Nearly 6% Higher Today ↗

October 28, 2022

The biotech is ceasing its internally funded efforts to develop a heterologous coronavirus booster.

Via The Motley Fool

A New BioTech Research Race Is Focused On Improving Life For MS Patients ↗

October 27, 2022

When the world is focused on a global pandemic no one saw coming four years ago, the attention given to escalating diseases with no known cure can be hidden from the public consciousness. This is...

Via Benzinga

Is BioNTech a Good Long-Term Buy? ↗

October 27, 2022

BioNTech has a burgeoning oncology portfolio up its sleeve.

Via The Motley Fool

Are Pfizer and Moderna Stocks Buys With a Potential COVID Surge Coming? ↗

October 26, 2022

There's still considerable near-term uncertainty for both of these vaccine makers.

Via The Motley Fool

JP Morgan Maintains Neutral Rating for BioNTech: Here's What You Need To Know ↗

October 24, 2022

JP Morgan has decided to maintain its Neutral rating of BioNTech (NASDAQ:BNTX) and lower its price target from $183.00 to $132.00. Shares of BioNTech are trading down 0.68% over the last 24 hours, at...

Via Benzinga

BioNTech to Report Third Quarter 2022 Financial Results and Operational Update on November 7, 2022

October 24, 2022

From BioNTech SE

Via GlobeNewswire

Why Huntington Bancshares Shares Surged Around 10%; Here Are 72 Biggest Movers From Friday ↗

October 24, 2022

Gainers Huadi International Group Co., Ltd. (NASDAQ: HUDI) jumped 89.3% to close at $58.92 on Friday.

Via Benzinga

Moderna, Amazon, Tesla, And Other Big Gainers From Friday ↗

October 24, 2022

U.S. stocks closed higher on Friday, with the Dow Jones gaining around 750 points. Here is the list of some big stocks recording gains in the previous session.

Via Benzinga

Why Novavax Stock Rose 12.57% on Friday ↗

October 21, 2022

Investors did an about-face after the stock slumped earlier in the week.

Via The Motley Fool

Why Are Vaccine Stocks MRNA, PFE, BNTX, NVAX Up Today? ↗

October 21, 2022

Vaccine stocks are flying higher on Friday on word that Pfizer will quadruple the price of its Covid-19 vaccine. Will others follow suit?

Via InvestorPlace

Twitter Rebuffs Elon Musk Layoff Plans Report, Toyota Cuts 2023's Production Target, Vaccine Makers Expect 3x Price Increase In COVID-19 Shot: Top Stories Friday, Oct. 21 ↗

October 21, 2022

Bloomberg

Via Benzinga

Why Boston Beer Shares Are Trading Higher? Here Are 52 Stocks Moving In Friday's Mid-Day Session ↗

October 21, 2022

Gainers Altamira Therapeutics Ltd. (NASDAQ: CYTO) surged 67% to $0.5484 after the company announced divestiture of its inner ear development assets.

Via Benzinga

Vaccine Makers Mull Price Increase For COVID-19 Boosters Amid Falling Demand ↗

October 21, 2022

Via Benzinga

Boston University's COVID-19 Created In Lab Research Comes Under Scrutiny ↗

October 20, 2022

Boston University created an artificial form of COVID-19 in a laboratory. Now, U.S. health officials have launched an inquiry into a controversial study. The Boston University research was designed to...

Via Benzinga

Why Moderna Stock Dropped Today ↗

October 19, 2022

Competition is intensifying.

Via The Motley Fool

< Previous 1 2

...

25 26 27 28 29 30 31 32 33

...

72 73 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.